Business Context and Reporting Period
Company: Creative Medical Technology Holdings, Inc. (CELZ)
Filing Type: Form 8-K (Current Report)
Date of Report: April 8, 2025
Reporting Period: Event date April 4, 2025 (Adoption of Clawback Policy) and April 8, 2025 (Nasdaq correspondence).
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document addresses corporate governance compliance rather than financial performance.
Material Changes
- Policy Adoption: On April 4, 2025, the Company adopted a Clawback Policy pursuant to Nasdaq Listing Rule 5608(b)(1) with retroactive effect to December 1, 2023.
- Compensation Impact: The Policy will have no impact on previously paid executive compensation as no incentive compensation subject to clawback was received by executive officers.
- Regulatory Status: The Company received a letter from Nasdaq on April 8, 2025, noting a prior failure to timely adopt and disclose the Policy in its original Form 10-K filings for fiscal years ended December 31, 2023, and December 31, 2024.
Outlook, Risks, and Management Commentary
Current Compliance Status: Nasdaq confirmed that the Company is currently in compliance with Nasdaq Listing Rules. The matter regarding the delayed adoption and disclosure is now closed.
Risks: The filing highlights a historical compliance gap regarding the timing of the Clawback Policy adoption and disclosure, though this has been remediated.
Investor Verification Checklist
- Verify the Company's current listing status on The Nasdaq Stock Market LLC.
- Review the Amended Annual Report on Form 10-K to confirm the Clawback Policy is properly filed as an exhibit.
- Confirm that no executive incentive compensation remains outstanding that could be subject to the retroactive policy.